5 citations · 5 across the 2 of their papers we have counts for
2 papers
stat.AP2023
Integration of Efficacy Biomarkers Together with Toxicity Endpoints in Immune-Oncology Dose Finding Studies
Yiding Zhang, Zhixing Xu, Hui Quan +1
The primary objective of phase I oncology studies is to establish the safety profile of a new treatment and determine the maximum tolerated dose (MTD). This is motivated by the dev…
stat.ME2019★ 5 cited
Latent Multivariate Log-Gamma Models for High-Dimensional Multi-Type Responses with Application to Daily Fine Particulate Matter and Mortality Counts
Zhixing Xu, Jonathan R. Bradley, Debajyoti Sinha
Tracking and estimating Daily Fine Particulate Matter (PM2.5) is very important as it has been shown that PM2.5 is directly related to mortality related to lungs, cardiovascular sy…